This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Pharmaceutical Unit Dose Packaging Market

Market Insights on Pharmaceutical Unit Dose Packaging covering sales outlook, demand forecast & up-to-date key trends

Pharmaceutical Unit Dose Packaging Market By Product Type (Blisters, Ampoules), Material (Plastics, Aluminium), End-Use (Ophthalmic, Injectable, Biologics, Wound Care) & Region - Forecast 2021-2031

About the Report

Unit dose packaging is a type of primary packaging, which constitutes the first level of containers used for packaging of pharmaceutical products. These include blisters, vials, ampoules, and prefilled syringes cartridges.

The increasing use of medications as a part of treatment prescribed for various ailments and for large vaccination programs undertaken by leading international organizations such as UNISEF, the World Health Organization (WHO), and others have been significantly fuelling the demand for pharmaceutical unit dose packaging solutions. Sales have been skyrocketing amid vaccination drives and treatment offered to contain COVID-19.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for pharmaceutical unit dose packaging. The report tracks the global sales of pharmaceutical unit dose packaging in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the pharmaceutical unit dose packaging industry.

Customize this Report

Let us know your requirement to get
100% FREE customization

How Historical Sales of Pharmaceutical Unit Dose Packaging Match Up with Future Outlook

The earliest attempts in unit dose dispensing were documented in the mid-60. Since then, in 1975 unit drug dose distribution was approved by board of directors in the American Society of Hospital Pharmacists (ASHP).

Over the past decade, increasing investment by healthcare institutions and biopharmaceutical firms in research and development of new medications and increasing government investment healthcare sector have aggressively enhanced the demand for pharmaceutical unit dose packaging.

The demand for pharmaceutical unit dose packaging is expected to surge exceptionally with the roll-out of COVID-19 treatment programs in addition to the regular diseases precautions, & treatments across the globe.

Besides this, consumers are largely inclined towards precautionary vaccination from the common diseases such as measles, polio, cancer, and many others, thus considerably rising the global demand for unit drug dose packaging consumption. According to the analysis, pharmaceutical unit dose packaging sales are likely tap double digit growth during the forecast period

Nowadays, pharmaceutical unit dose packaging formats such as blister, vials, pre-filled syringes carriages and ampoules are in high demand, particularly in vaccination intended to contain chronic ailments and more recently to fulfil COVID-19 treatment needs. Owing to the growing demand from pharmaceutical packaging solutions for high end drugs, medicines, and vaccines, the market is expected to grow during the pandemic period.

The increasing demand for these pharmaceutical products will enable the pharmaceutical unit dose packaging market reach US$ 26 billion by 2021. Increasing prevalence of infectious diseases such as influenza, hepatitis, Ebola, tuberculosis, swine flu, and others are driving the product development.

These developments are indicative of a positive outlook for the market. Against this backdrop, the report forecasts the pharmaceutical unit dose packaging market to grow at 14.7% CAGR through 2031.

Convenience and Ease in Handling: Key Advantages of Pharmaceutical Unit Dose Packaging

Unit dose blisters, vials, and pre-filled syringes ensure accurate delivery of the drug. This in turn helps patients to self-administer the medicine without any prior training for the safe administration of drugs. Also, the use of single or unit pharmaceutical doses results in a decrease in the medication error such as reduced dosing and risk of microbial contamination. They also help in eliminating the risk multiple dosing of the drug.

Prefilled syringes can be disposed of easily compared to traditional syringes as the needle is drawn inside the barrel after use or it can be retractable. Furthermore, it also serves the additional advantage of having electronic documentation for easy monitoring and ease of identifying potentially damaged containers.

Pharmaceutical unit dose packaging not only offers greater convenience to patients in administering the medicine, but it results in a reduction in unnecessary costs for the patient.

Ismail Sutaria
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Impact of Coronavirus Pandemic on Pharmaceutical Unit Dose Packaging Consumption?

The demand for vaccines was projected to reach 4.8 billion doses in 2019, according to the World Health Organization (WHO), which showcases an improvement by nearly 20 percent from last year, thanks to the increasing demand from the Asia and Africa markets. But the recent coronavirus pandemic have triggered the demand to record new as a result of the urgency of vaccination.

Local government organizations and drug development companies across the globe are placing huge orders worth millions of dollars. This has been compelling the makers of blister, syringes and vials to add up production capacity.

The manufactures also are ramping up their production facilities for pharmaceutical unit dose packaging containers to fulfill the global needs.

  • In July 2020, the Becton, Dickinson & Company partnered with U.S. Government on $70 Million manufacturing infrastructure project for Mass Vaccination Campaigns.
  • Stevanato Group has received an order from the global nonprofit Coalition for Epidemic Preparedness Innovations (CEPI) for 100 million vials.

What is the Impact of Glass Fragility and Delamination on Pharmaceutical Unit Dose Packaging Sales?

The fragility of glass is one of the major concerns for manufacturers and consumers. Delamination of glass occurs from glass bits and surface degradation which is can be observed as chips within the medicinal products. Delamination is a serious problem because any foreign particle injected may be extremely hazardous for the patient.

Furthermore, long time span of storage and drug delivery might cause visible glass delamination, which can create enormous risks. In recent years, delamination in glass ampoules has led to frequent product recalls, patient safety issues, and economic losses. Product recalls in recent years have caused pharmaceutical companies severe economic losses, going into millions, primarily due to glass delamination.

According to the Corning Inc. “A glass supplier for the pharmaceutical industry, delamination, seemingly minor occurrence, can then have costly consequences. One, single recall can cost a pharma company US$ 250 Mn”

Hence, glass fragility and glass delamination are perceived as major risks in the pharmaceutical sector.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

Sound Pharmaceutical Base Supports Growth in U.S.

According to the report, the United States is likely to exhibit consistent demand for pharmaceutical unit dose packaging products over the next five years. One of the key aspects supporting market growth is that, the U.S. is the place for most of the top pharmaceutical drugs & medications research and development and manufacturing facilities who specifically deal with new product developments for various diseases.

Johnson & Johnson, Pfizer Inc., AbbVie Inc., Eli Lilly and Company, and many others have their R&D and manufacturing facilities in the U.S. which plays an important role in fuelling sales of pharmaceutical unit dose packaging solutions.

On the other hand, the top suppliers of pharmaceutical unit dose packaging products such as West Pharmaceutical Services, Inc., Berry Global, Inc., Aptar Group, Inc., Becton, Dickinson & Company, and Catalent, Inc. are tirelessly supplying their services to the customers in the U.S.

What is Driving German Pharmaceutical Unit Dose Packaging Market?

The Federal Statistical Office Germany has reported that healthcare spending rose by 4% in 2018 from 2017 in Germany. In 2018, the country’s healthcare expenditure accounted for 11.7% of the GDP. Moreover, country’s projected healthcare spending exceeded US$ 505 bn in 2020, creating a conducive environment for the expansion of the pharmaceutical unit dose packaging market.

Also presence of large packaging manufacturing companies such as Gerresheimer AG., SCHOTT AG, SGD S.A., and Bormioli Pharma is continuously supporting the expansion in Germany.

  • In 2020, SCHOTT AG delivers vials to pack 2 billion dosages of Coronavirus vaccines.
  • In 2019, Gerresheimer AG opened a new plant for the production of pharmaceutical primary plastic packaging in China.

How Have Pharmaceutical Unit Dose Packaging Products Made Their Place in the U.K.?

Alzheimer’s and some other disease have long been in the U.K. for which the healthcare units and hospitals are using innovative and advanced methods for dispensing medications in pouches in the UK. The Alzheimer’s Research Trust states that the total of patients with dementia in the U.K. to be over 1.5 million in 2020. Healthcare units can form an important measure of the care strategy, helping the patients and nurses to manage medicines in a suitable way. Patients with other psychiatric illness such as schizophrenia also need critical care supplies.

Here comes the roles of pharmaceutical unit dose packaging solution that shows the gradient to fulfill the demand of these patients. Single or unit pharmaceutical drug doses results in a decrease in the medication error with reduction in the risk of microbial contamination. Also, convenience and ease in handling of these pharmaceutical unit dose packaging solution will help them in providing accurate and measured medications to the patients.

China’s Entrance to Vaccine Development Market

China is organizing to bring reasonable vaccines to the world that will follow all the standards for safety, quality and security. A few multinational organizations from the U.K. the U.S., and Germany have long controlled the global vaccine development and manufacturing industry. However some companies from China are now becoming key manufacturers of vaccines and have begun to sell these vaccines in the global market, competition is expected to rise and prices are set to fall.

  • Recently in January 2021, Indonesia gave approval to China’s Sinovac Biotech's Covid-19 vaccine. Besides this, Malaysia Pharmaniaga Bhd has signed an agreement with China’s Sinovac to purchase 14 million doses of ready-to-fill COVID-19 vaccines.

At the Global Vaccine Summit in June 2020, China pledged a new US$ 20 million commitment to support GAVI’s strategic work for the 2021-2025 period, acknowledging the Alliance's vital work in supplying children around the world with life-saving vaccines.

Is India Showing Growth Prospects?

India’s epidemiological outline is changing, so demand is expected to increase for medicines and drugs for ailments affecting central nervous system, cardio vascular hitches, and other chronic infections.

Together these factors mean that India represents a promising market for global pharmaceutical manufacturers. More than that, India has a growing pharmaceutical industry of its own. It is likely to become a competitor of global pharmaceutical industry in some key areas, and a potential partner in others.

Increasing buying power and epidemiological changes should spur dramatic growth in sales volumes of medicines and drugs and thereby opening new opportunities for pharmaceutical unit dose packaging market players.

Category-wise Insights

Opportunities Increasing for Prefilled Syringes Cartridges Sales

Mass vaccination programs would be significantly enhanced by having the vaccines previously filled in syringes cartridges, certainly the ones that do not need super low temperature. These solutions do not require high proficiency and training.

Their sales are accelerated because they do not need scheduling the vaccine on the front line, possibly reducing interface time for the patient vaccinator. Driven by these factors, prefilled syringes cartridges segment is projected account for nearly 1/4th of the market share by 2031. Companies operating in the market are already capitalizing on this opportunity.

  • As COVID-19 demand surges, Becton, Dickinson and Company plans $1.2 bn expansion to boost prefilled syringe output by 50%.
  • Retractable Technologies signed two contracts with the U.S. government worth $138 million to supply syringes for a vaccine.

However, in the global pharmaceutical unit dose packaging market, blisters and vials are the most sought after product segments, globally preferred by consumers. Cumulatively these segments will continue accounting for over 3/5th of the global share among products through 2031. Blisters offer greater accuracy and upfront usage in the pills, capsules and tablets, which are the leading causes behind dominance of the segment across all the regions.

Pharmaceutical Unit Dose Packaging Market Download Report Brochure

What is the Market Share of Glass Material?

By material, maximum number of manufactures prefer to make primary packaging from glass. This is because glass is non-reactive and will therefore not react with the inner contents. It’s clear and shiny appeal guarantees the purity of the drug. Due to these factors, the glass segment is anticipated to witness expansion at 4.9x times in the global pharmaceutical unit dose packaging market.

Besides this, in 2020 the segment have captured nearly 1/3rd of the total pharmaceutical unit dose packaging market share due to its multipurpose applications in the pharmaceutical packaging solutions.

How Big is the Opportunity in the Injectable End Uses?

By end use, the injectable segment is expected to dominate, accounting for more than 1/4th of the revenue share by 2031. Besides this, the segment is estimated to expand by five folds on the backdrop of rising consumption of vaccines and injectable drugs by the consumers across the globe.

Insecure injection exercises, including the wrong use of medications for more than one patient can cause serious drug safety concerns such as bacterial contaminations transferred between patients.

To report confusion concerning the existing product terminology, the FDA is creating a new packaging type term “single-patient-use” product, to address the requisite for telling a package that contains injectable medical product that is intended to be used on a single patient. A pharmaceutical unit dose packaging is designed for use with a single patient as a single infusion using ampoules, vials, and prefilled syringes.

Competitive Landscape

The global pharmaceutical unit dose packaging market is fragmented in nature, exhibiting the presence of many globally established and local players. In order to retain their competitive edge, leading players are offering products according to industry necessities.

Some of the companies operating in the pharmaceutical unit dose packaging market are aiming at strategic acquisition of new market entrants precisely who deal with sustainable pharmaceutical unit dose packaging products.

For instance,

  • In November 2020, Becton, Dickinson and Company acquired the Medical Business Assets of CUBEX LLC, broadening automated dispensing portfolio across Care Continuum.
  • In January 2020, Sonoco acquired Thermoform Engineered Quality, LLC, and Plastique Holdings, LTD, (together TEQ), a global manufacturer of thermoformed packaging serving healthcare, medical device, and consumer markets.

Some of the leading companies operating in the market are:

(Global Players)

  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • SGD SA
  • Stevanato Group S.p.a.
  • Klockner Pentaplast Group
  • UDG Healthcare plc
  • Amcor plc
  • Berry Global, Inc.
  • Comar LLC
  • Constantia Flexibles Group GmbH
  • Nipro Corporation
  • Catalent, Inc.
  • Becton, Dickinson and Company
  • Adelphi Healthcare Packaging
  • Winpak Ltd.
  • Pacific Vial Manufacturing Inc.
  • Sonoco Products Company
  • WestRock Company
  • AptarGroup, Inc.

(APAC/China based Players)

  • Shanghai Tongpeng Electric Material Co., Ltd 
  • Tonbay Industry Co., Ltd.
  • Borosil Limited
  • Piramal Glass Private Limited
  • Jinan Youlyy Industrial Co., Ltd
  • SVM ENTERPRISES
  • Khemka Glass
  • Taj Pharma India
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Avesta Continental Pack

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.

Scope of the Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2015-2020

Market Analysis

US$ Billion for Value and Thousand Tons for Volume

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa

Key Segments Covered

Product, Material,  End Use, and Region

Key Companies Profiled

(Global Players)

  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • SGD SA
  • Stevanato Group S.p.a.
  • Klockner Pentaplast Group
  • UDG Healthcare plc
  • Amcor plc
  • Berry Global, Inc.
  • Comar LLC
  • Constantia Flexibles Group GmbH
  • Nipro Corporation
  • Catalent, Inc.
  • Becton, Dickinson and Company
  • Adelphi Healthcare Packaging
  • Winpak Ltd.
  • Pacific Vial Manufacturing Inc.
  • Sonoco Products Company
  • WestRock Company
  • AptarGroup, Inc.

(APAC/China based Players)

  • Shanghai Tongpeng Electric Material Co., Ltd 
  • Tonbay Industry Co., Ltd.
  • Borosil Limited
  • Piramal Glass Private Limited
  • Jinan Youlyy Industrial Co., Ltd
  • SVM ENTERPRISES
  • Khemka Glass
  • Taj Pharma India
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Avesta Continental Pack

Report Coverage

Market Forecast, Brand share analysis, Competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Pharmaceutical unit dose packaging Market by Category

Product:

  • Blisters Pharmaceutical Unit Dose Packaging
  • Ampoules Pharmaceutical Unit Dose Packaging
  • Vials Pharmaceutical Unit Dose Packaging
  • Prefilled Syringes Cartridges

Material:

  • Plastic Pharmaceutical Unit Dose Packaging
  • Aluminum Pharmaceutical Unit Dose Packaging
  • Glass Pharmaceutical Unit Dose Packaging
  • Paper & Paperboard Pharmaceutical Unit Dose Packaging

End Use:

  • Ophthalmic
  • Injectable
  • Biologics
  • Wound Care
  • Respiratory Therapy
  • Orals

Region:

  • North America
  • Latin America
  • Europe
  • Middle East and Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

Frequently Asked Questions

Europe currently leads the global market for pharmaceutical unit dose packaging. Sales in Europe are expected to account for over 1/4th of total demand by 2021.

Vial is the most preferred pharmaceutical unit dose packaging product in the market. The demand for vial is expected to increase over the forecast period owing to their higher doses per vial capacity and non-reactiveness with the contents.

As per FMI analysis, injectable and oral end use segments are expected to exhibit high demand, increasing the sales of pharmaceutical unit dose packaging.

Some of the leading companies offering pharmaceutical unit dose packaging are Gerresheimer AG, Stevanato Group, SCHOTT AG, Klockner Pentaplast Group, Pacific Vial Manufacturing Inc., Adelphi Healthcare Packaging, West Pharmaceutical Services, Inc. Nipro Corporation and among others.

Table of Content

1. Executive Summary

    1.1. Global Market Overview

    1.2. Market Analysis

    1.3. Analysis and Recommendations

2. Market Overview

    2.1. Market Definition

    2.2. Market Taxonomy 

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Product USPs / Features

    4.3. Strategic Promotional Strategies

5. Global Pharmaceutical Unit Dose Packaging Market  Demand Analysis 2015-2020 and Forecast, 2021-2031

    5.1. Historical Market Volume (Tons) and Value (US$ Mn) Analysis, 2015-2020

    5.2. Current and Future Market Volume (Tons) and Value (US$ Mn) Projections, 2021-2031

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Pharmaceutical Unit Dose Packaging Market - Pricing Analysis

    6.1. Regional Pricing Analysis, By Product 

    6.2. Pricing Break-up

    6.3. Global Average Pricing Analysis Benchmark

7. Global Pharmaceutical Unit Dose Packaging Market Demand (Value in US$ Mn) Analysis 2015–2020 and Forecast, 2021–2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2015–2020

    7.2. Current and Future Market Value (US$ Mn) Analysis, 2021–2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Global Packaging Market Overview

    8.2. Global Flexible and Rigid Packaging Market Outlook

    8.3. Global Pharmaceutical Unit Dose Packaging Market Outlook

    8.4. Consumer Sentiment Analysis

    8.5. Macroeconomic Indicators & Correlation Analysis

        8.5.1. Global GDP Growth Outlook

        8.5.2. GDP Per Capita

        8.5.3. Manufacturing Value Added

        8.5.4. Industrial Production

    8.6. Forecast Factors

    8.7. Value Chain Analysis

        8.7.1. Key Participants

            8.7.1.1. Raw Material Suppliers

            8.7.1.2. Pharmaceutical Unit Dose Packaging Manufacturers

            8.7.1.3. End Users

        8.7.2. Profitability Margin

    8.8. Market Dynamics

        8.8.1. Drivers

        8.8.2. Restraints

        8.8.3. Opportunities

    8.9. Impact of COVID-19

        8.9.1. Current Statistics and Probable Future Impact

        8.9.2. Impact of COVID-19 on Pharmaceutical Unit Dose Packaging Market

        8.9.3. Recovery Scenario – Short-term, Mid-term and Long-term Impact

9. Global Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031, By Product

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis By Product, 2015 - 2020

    9.3. Current and Future Market Size (US$ Mn) and Volume (Tons) Analysis and Forecast By Product, 2021 - 2031

        9.3.1. Blisters

        9.3.2. Ampoules

        9.3.3. Vials

        9.3.4. Prefilled Syringes Cartridges

    9.4. Market Attractiveness Analysis By Product

10. Global Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031, by Material

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis By Material, 2015 - 2020

    10.3. Current and Future Market Size (US$ Mn) and Volume (Tons) Analysis and Forecast By Material, 2021 - 2031

        10.3.1. Plastic

            10.3.1.1. Polyethylene(PE)

                10.3.1.1.1. High Density Polyethylene (HDPE)

                10.3.1.1.2. Low Density Polyethylene (LDPE)

            10.3.1.2. Polypropylene

            10.3.1.3. Poly vinyl chloride(PVC)

            10.3.1.4. Polyethylene Terephthalate (PET)

        10.3.2. Aluminum

        10.3.3. Glass

        10.3.4. Paper & Paperboard

    10.4. Market Attractiveness Analysis By Material

11. Global Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031, By End Use

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis End Use, 2015 - 2020

    11.3. Current and Future Market Size (US$ Mn) and Volume (Tons) Analysis and Forecast By End Use, 2021 - 2031

        11.3.1. Ophthalmic

        11.3.2. Injectable

        11.3.3. Biologics

        11.3.4. Wound Care

        11.3.5. Respiratory Therapy

        11.3.6. Orals 

    11.4. Market Attractiveness Analysis End Use 

12. Global Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis By Region, 2015 - 2020

    12.3. Current Market Size (US$ Mn) and Volume (Tons) Analysis and Forecast By Region, 2021 - 2031

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Middle East and Africa (MEA)

        12.3.5. East Asia

        12.3.6. South Asia

        12.3.7. Oceania

    12.4. Market Attractiveness Analysis By Region

13. North America Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2020

    13.3. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2021 - 2031

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Material

        13.3.3. By Product

        13.3.4. By End Use

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Material

        13.4.3. By Product

        13.4.4. By End Use

    13.5. Key Market Participants - Intensity Mapping

14. Latin America Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2020

    14.3. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2021 - 2031

        14.3.1. By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Material

        14.3.3. By Product

        14.3.4. By End Use

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Material

        14.4.3. By Product

        14.4.4. By End Use

    14.5. Key Market Participants - Intensity Mapping

15. Europe Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2020

    15.3. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2021 - 2031

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Material

        15.3.3. By Product

        15.3.4. By End Use

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Material

        15.4.3. By Product

        15.4.4. By End Use

    15.5. Key Market Participants - Intensity Mapping

16. Middle East and Africa Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2020

    16.3. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2021 - 2031

        16.3.1. By Country

            16.3.1.1. GCC Countries

            16.3.1.2. Turkey

            16.3.1.3. Northern Africa

            16.3.1.4. South Africa

            16.3.1.5. Rest of Middle East and Africa

        16.3.2. By Material

        16.3.3. By Product

        16.3.4. By End Use

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Material

        16.4.3. By Product

        16.4.4. By End Use

    16.5. Key Market Participants - Intensity Mapping

17. East Asia Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2020

    17.3. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2021 - 2031

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Material

        17.3.3. By Product

        17.3.4. By End Use

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Material

        17.4.3. By Product

        17.4.4. By End Use

    17.5. Key Market Participants - Intensity Mapping

18. South Asia Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2020

    18.3. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2021 - 2031

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Thailand

            18.3.1.3. Indonesia

            18.3.1.4. Malaysia

            18.3.1.5. Rest of South Asia

        18.3.2. By Material

        18.3.3. By Product

        18.3.4. By End Use

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Material

        18.4.3. By Product

        18.4.4. By End Use

    18.5. Key Market Participants - Intensity Mapping

19. Oceania Pharmaceutical Unit Dose Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2020

    19.3. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2021 - 2031

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Material

        19.3.3. By Product

        19.3.4. By End Use

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Material

        19.4.3. By Product

        19.4.4. By End Use

    19.5. Key Market Participants - Intensity Mapping

20. Pharmaceutical Unit Dose Packaging Market Country-wise Analysis and Forecast

    20.1. U.S. Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.1.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.1.1.1. By Material

            20.1.1.2. By Product

            20.1.1.3. By End Use

    20.2. Canada Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.2.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.2.1.1. By Material

            20.2.1.2. By Product

            20.2.1.3. By End Use

    20.3. Brazil Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.3.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.3.1.1. By Material

            20.3.1.2. By Product

            20.3.1.3. By End Use

    20.4. Mexico Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.4.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.4.1.1. By Material

            20.4.1.2. By Product

            20.4.1.3. By End Use

    20.5. Germany Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.5.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.5.1.1. By Material

            20.5.1.2. By Product

            20.5.1.3. By End Use

    20.6. Italy Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.6.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.6.1.1. By Material

            20.6.1.2. By Product

            20.6.1.3. By End Use

    20.7. France Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.7.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.7.1.1. By Material

            20.7.1.2. By Product

            20.7.1.3. By End Use

    20.8. U.K. Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.8.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.8.1.1. By Material

            20.8.1.2. By Product

            20.8.1.3. By End Use

    20.9. GCC Countries Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.9.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.9.1.1. By Material

            20.9.1.2. By Product

            20.9.1.3. By End Use

    20.10. Turkey Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.10.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.10.1.1. By Material

            20.10.1.2. By Product

            20.10.1.3. By End Use

    20.11. China Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.11.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.11.1.1. By Material

            20.11.1.2. By Product

            20.11.1.3. By End Use

    20.12. Japan Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.12.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.12.1.1. By Material

            20.12.1.2. By Product

            20.12.1.3. By End Use

    20.13. India Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.13.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.13.1.1. By Material

            20.13.1.2. By Product

            20.13.1.3. By End Use

    20.14. Australia Pharmaceutical Unit Dose Packaging Market Analysis 2020 & 2030

        20.14.1. Market Volume (Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.14.1.1. By Material

            20.14.1.2. By Product

            20.14.1.3. By End Use

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Pharmaceutical Unit Dose Packaging Companies 

    21.2. Market Share Analysis of Top Players

    21.3. Market Presence Analysis

        21.3.1. By Regional footprint of Players

        21.3.2. Product foot print by Players

        21.3.3. Channel Foot Print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. UDG Healthcare plc

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Profitability by Market Segments

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

                22.3.1.5.1. Marketing Strategy

                22.3.1.5.2. Product Strategy

                22.3.1.5.3. Channel Strategy

        22.3.2. Amcor plc

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Profitability by Market Segments

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

                22.3.2.5.1. Marketing Strategy

                22.3.2.5.2. Product Strategy

                22.3.2.5.3. Channel Strategy

        22.3.3. Gerresheimer AG 

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Profitability by Market Segments

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

                22.3.3.5.1. Marketing Strategy

                22.3.3.5.2. Product Strategy

                22.3.3.5.3. Channel Strategy

        22.3.4. Berry Global, Inc.

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Profitability by Market Segments

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

                22.3.4.5.1. Marketing Strategy

                22.3.4.5.2. Product Strategy

                22.3.4.5.3. Channel Strategy

        22.3.5. Schott AG

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Profitability by Market Segments

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

                22.3.5.5.1. Marketing Strategy

                22.3.5.5.2. Product Strategy

                22.3.5.5.3. Channel Strategy

        22.3.6. SGD SA

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Profitability by Market Segments

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

                22.3.6.5.1. Marketing Strategy

                22.3.6.5.2. Product Strategy

                22.3.6.5.3. Channel Strategy

        22.3.7. Stevanato Group S.p.a.

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Profitability by Market Segments

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

                22.3.7.5.1. Marketing Strategy

                22.3.7.5.2. Product Strategy

                22.3.7.5.3. Channel Strategy

        22.3.8. Comar LLC

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Profitability by Market Segments

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

                22.3.8.5.1. Marketing Strategy

                22.3.8.5.2. Product Strategy

                22.3.8.5.3. Channel Strategy

        22.3.9. Constantia Flexibles Group GmbH

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Profitability by Market Segments

            22.3.9.4. Sales Footprint

            22.3.9.5. Strategy Overview

                22.3.9.5.1. Marketing Strategy

                22.3.9.5.2. Product Strategy

                22.3.9.5.3. Channel Strategy

        22.3.10. Nipro Corporation

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Profitability by Market Segments

            22.3.10.4. Sales Footprint

            22.3.10.5. Strategy Overview

                22.3.10.5.1. Marketing Strategy

                22.3.10.5.2. Product Strategy

                22.3.10.5.3. Channel Strategy

        22.3.11. Catalent, Inc.

            22.3.11.1. Overview

            22.3.11.2. Product Portfolio

            22.3.11.3. Profitability by Market Segments

            22.3.11.4. Sales Footprint

            22.3.11.5. Strategy Overview

                22.3.11.5.1. Marketing Strategy

                22.3.11.5.2. Product Strategy

                22.3.11.5.3. Channel Strategy

        22.3.12. Becton, Dickinson and Company

            22.3.12.1. Overview

            22.3.12.2. Product Portfolio

            22.3.12.3. Profitability by Market Segments

            22.3.12.4. Sales Footprint

            22.3.12.5. Strategy Overview

                22.3.12.5.1. Marketing Strategy

                22.3.12.5.2. Product Strategy

                22.3.12.5.3. Channel Strategy

        22.3.13. Adelphi Healthcare Packaging

            22.3.13.1. Overview

            22.3.13.2. Product Portfolio

            22.3.13.3. Profitability by Market Segments

            22.3.13.4. Sales Footprint

            22.3.13.5. Strategy Overview

                22.3.13.5.1. Marketing Strategy

                22.3.13.5.2. Product Strategy

                22.3.13.5.3. Channel Strategy

        22.3.14. Winpak Ltd.

            22.3.14.1. Overview

            22.3.14.2. Product Portfolio

            22.3.14.3. Profitability by Market Segments

            22.3.14.4. Sales Footprint

            22.3.14.5. Strategy Overview

                22.3.14.5.1. Marketing Strategy

                22.3.14.5.2. Product Strategy

                22.3.14.5.3. Channel Strategy

        22.3.15. Pacific Vial Manufacturing Inc.

            22.3.15.1. Overview

            22.3.15.2. Product Portfolio

            22.3.15.3. Profitability by Market Segments

            22.3.15.4. Sales Footprint

            22.3.15.5. Strategy Overview

                22.3.15.5.1. Marketing Strategy

                22.3.15.5.2. Product Strategy

                22.3.15.5.3. Channel Strategy

        22.3.16. Sonoco Products Company

            22.3.16.1. Overview

            22.3.16.2. Product Portfolio

            22.3.16.3. Profitability by Market Segments

            22.3.16.4. Sales Footprint

            22.3.16.5. Strategy Overview

                22.3.16.5.1. Marketing Strategy

                22.3.16.5.2. Product Strategy

                22.3.16.5.3. Channel Strategy

        22.3.17. WestRock Company

            22.3.17.1. Overview

            22.3.17.2. Product Portfolio

            22.3.17.3. Profitability by Market Segments

            22.3.17.4. Sales Footprint

            22.3.17.5. Strategy Overview

                22.3.17.5.1. Marketing Strategy

                22.3.17.5.2. Product Strategy

                22.3.17.5.3. Channel Strategy

        22.3.18. Klockner Pentaplast Group

            22.3.18.1. Overview

            22.3.18.2. Product Portfolio

            22.3.18.3. Profitability by Market Segments

            22.3.18.4. Sales Footprint

            22.3.18.5. Strategy Overview

                22.3.18.5.1. Marketing Strategy

                22.3.18.5.2. Product Strategy

                22.3.18.5.3. Channel Strategy

        22.3.19. AptarGroup, Inc.

            22.3.19.1. Overview

            22.3.19.2. Product Portfolio

            22.3.19.3. Profitability by Market Segments

            22.3.19.4. Sales Footprint

            22.3.19.5. Strategy Overview

                22.3.19.5.1. Marketing Strategy

                22.3.19.5.2. Product Strategy

                22.3.19.5.3. Channel Strategy

        22.3.20. West Pharmaceutical Services, Inc.

            22.3.20.1. Overview

            22.3.20.2. Product Portfolio

            22.3.20.3. Profitability by Market Segments

            22.3.20.4. Sales Footprint

            22.3.20.5. Strategy Overview

                22.3.20.5.1. Marketing Strategy

                22.3.20.5.2. Product Strategy

                22.3.20.5.3. Channel Strategy

    22.4. APAC / China Based Manufacturers

        22.4.1. Shanghai Tongpeng Electric Material Co., Ltd.

            22.4.1.1. Overview

            22.4.1.2. Product Portfolio

            22.4.1.3. Profitability by Market Segments

            22.4.1.4. Sales Footprint

            22.4.1.5. Strategy Overview

                22.4.1.5.1. Marketing Strategy

                22.4.1.5.2. Product Strategy

                22.4.1.5.3. Channel Strategy

        22.4.2. Tonbay Industry Co., Ltd.

            22.4.2.1. Overview

            22.4.2.2. Product Portfolio

            22.4.2.3. Profitability by Market Segments

            22.4.2.4. Sales Footprint

            22.4.2.5. Strategy Overview

                22.4.2.5.1. Marketing Strategy

                22.4.2.5.2. Product Strategy

                22.4.2.5.3. Channel Strategy

        22.4.3. Borosil Limited

            22.4.3.1. Overview

            22.4.3.2. Product Portfolio

            22.4.3.3. Profitability by Market Segments

            22.4.3.4. Sales Footprint

            22.4.3.5. Strategy Overview

                22.4.3.5.1. Marketing Strategy

                22.4.3.5.2. Product Strategy

                22.4.3.5.3. Channel Strategy

        22.4.4. Piramal Glass Private Limited

            22.4.4.1. Overview

            22.4.4.2. Product Portfolio

            22.4.4.3. Profitability by Market Segments

            22.4.4.4. Sales Footprint

            22.4.4.5. Strategy Overview

                22.4.4.5.1. Marketing Strategy

                22.4.4.5.2. Product Strategy

                22.4.4.5.3. Channel Strategy

        22.4.5. Jinan Youlyy Industrial Co., Ltd

            22.4.5.1. Overview

            22.4.5.2. Product Portfolio

            22.4.5.3. Profitability by Market Segments

            22.4.5.4. Sales Footprint

            22.4.5.5. Strategy Overview

                22.4.5.5.1. Marketing Strategy

                22.4.5.5.2. Product Strategy

                22.4.5.5.3. Channel Strategy

        22.4.6. SVM ENTERPRISES

            22.4.6.1. Overview

            22.4.6.2. Product Portfolio

            22.4.6.3. Profitability by Market Segments

            22.4.6.4. Sales Footprint

            22.4.6.5. Strategy Overview

                22.4.6.5.1. Marketing Strategy

                22.4.6.5.2. Product Strategy

                22.4.6.5.3. Channel Strategy

        22.4.7. Khemka Glass

            22.4.7.1. Overview

            22.4.7.2. Product Portfolio

            22.4.7.3. Profitability by Market Segments

            22.4.7.4. Sales Footprint

            22.4.7.5. Strategy Overview

                22.4.7.5.1. Marketing Strategy

                22.4.7.5.2. Product Strategy

                22.4.7.5.3. Channel Strategy

        22.4.8. Taj Pharma India

            22.4.8.1. Overview

            22.4.8.2. Product Portfolio

            22.4.8.3. Profitability by Market Segments

            22.4.8.4. Sales Footprint

            22.4.8.5. Strategy Overview

                22.4.8.5.1. Marketing Strategy

                22.4.8.5.2. Product Strategy

                22.4.8.5.3. Channel Strategy

        22.4.9. Shandong Pharmaceutical Glass Co., Ltd.

            22.4.9.1. Overview

            22.4.9.2. Product Portfolio

            22.4.9.3. Profitability by Market Segments

            22.4.9.4. Sales Footprint

            22.4.9.5. Strategy Overview

                22.4.9.5.1. Marketing Strategy

                22.4.9.5.2. Product Strategy

                22.4.9.5.3. Channel Strategy

        22.4.10. Avesta Continental Pack

            22.4.10.1. Overview

            22.4.10.2. Product Portfolio

            22.4.10.3. Profitability by Market Segments

            22.4.10.4. Sales Footprint

            22.4.10.5. Strategy Overview

                22.4.10.5.1. Marketing Strategy

                22.4.10.5.2. Product Strategy

                22.4.10.5.3. Channel Strategy

*The above list is indicative in nature and is subject to change during the course of research

23. Assumption and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Product, 2015H-2031F

Table 02: Global Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Product, 2015H-2028F

Table 03: Global Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Material, 2015H-2031F

Table 04: Global Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Material, 2015H-2031F

Table 05: Global Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By End Use, 2015H-2031F

Table 06: Global Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By End Use, 2015H-2028F

Table 07: Global Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Region, 2015H-2031F

Table 08: Global Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Region, 2015H-2031F

Table 09: North America Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Product, 2015H-2031F

Table 10: North America Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Product, 2015H-2028F

Table 11: North America Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Material, 2015H-2031F

Table 12: North America Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Material, 2015H-2031F

Table 13: North America Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By End Use, 2015H-2031F

Table 14: North America Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By End Use, 2015H-2028F

Table 15: North America Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Country, 2015H-2031F

Table 16: North America Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Country, 2015H-2028F

Table 17: Latin America Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Product, 2015H-2031F

Table 18: Latin America Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Product, 2015H-2028F

Table 19: Latin America Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Material, 2015H-2031F

Table 20: Latin America Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Material, 2015H-2031F

Table 21: Latin America Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By End Use, 2015H-2031F

Table 22: Latin America Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By End Use, 2015H-2028F

Table 23: Latin America Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Country, 2015H-2031F

Table 24: Latin America Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Country, 2015H-2028F

Table 25: Europe Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Product, 2015H-2031F

Table 26: Europe Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Product, 2015H-2028F

Table 27: Europe Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Material, 2015H-2031F

Table 28: Europe Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Material, 2015H-2031F

Table 29: Europe Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By End Use, 2015H-2031F

Table 30: Europe Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By End Use, 2015H-2028F

Table 31: Europe Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Country, 2015H-2031F

Table 32: Europe Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Country, 2015H-2031F

Table 33: MEA Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Product, 2015H-2031F

Table 34: MEA Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Product, 2015H-2028F

Table 35: MEA Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Material, 2015H-2031F

Table 36: MEA Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Material, 2015H-2031F

Table 37: MEA Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By End Use, 2015H-2031F

Table 38: MEA Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By End Use, 2015H-2028F

Table 39: MEA Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Country, 2015H-2031F

Table 40: MEA Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Country, 2015H-2028F

Table 41: East Asia Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Product, 2015H-2031F

Table 42: East Asia Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Product, 2015H-2028F

Table 43: East Asia Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Material, 2015H-2031F

Table 44: East Asia Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Material, 2015H-2031F

Table 45: East Asia Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By End Use, 2015H-2031F

Table 46: East Asia Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By End Use, 2015H-2028F

Table 47: East Asia Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Country, 2015H-2031F

Table 48: East Asia Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Country, 2015H-2028F

Table 49: South Asia Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Product, 2015H-2031F

Table 50: South Asia Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Product, 2015H-2028F

Table 51: South Asia Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Material, 2015H-2031F

Table 52: South Asia Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Material, 2015H-2031F

Table 53: South Asia Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By End Use, 2015H-2031F

Table 54: South Asia Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By End Use, 2015H-2028F

Table 55: South Asia Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Country, 2015H-2031F

Table 56: South Asia Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Country, 2015H-2028F

Table 57: Oceania Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Product, 2015H-2031F

Table 58: Oceania Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Product, 2015H-2028F

Table 59: Oceania Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Material, 2015H-2031F

Table 60: Oceania Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Material, 2015H-2031F

Table 61: Oceania Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By End Use, 2015H-2031F

Table 62: Oceania Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By End Use, 2015H-2028F

Table 63: Oceania Pharmaceutical Unit Dose Packaging Market Value (US$ Bn) Analysis By Country, 2015H-2031F

Table 64: Oceania Pharmaceutical Unit Dose Packaging Market Volume (‘000 Tons) Analysis By Country, 2015H-2028F

Table 65: U.S. Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 66: Canada Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 67: Brazil Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 68: Mexico Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 69: Germany Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 70: Italy Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 71: France Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 72: U.K. Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 73: GCC Countries Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 74: Turkey Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 75: China Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 76: Japan Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 77: India Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Table 78: Australia Pharmaceutical Unit Dose Packaging Market Analysis by Product, Material and End Use

Ismail Sutaria
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Pharmaceutical Unit Dose Packaging Market Share Analysis By Product, 2021E & 2031F

Figure 2: Global Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Product, 2020A-2031F

Figure 3: Global Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Product, 2021E-2031F

Figure 4: Global Pharmaceutical Unit Dose Packaging Market Share Analysis By Material, 2021E & 2031F

Figure 5: Global Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Material, 2020A-2031F

Figure 6: Global Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Material, 2021E-2031F

Figure 7: Global Pharmaceutical Unit Dose Packaging Market Share Analysis By End Use, 2021E & 2031F

Figure 8: Global Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By End Use, 2020A-2031F

Figure 9: Global Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By End Use, 2021E-2031F

Figure 10: Global Pharmaceutical Unit Dose Packaging Market Share Analysis By Region, 2021E & 2031F

Figure 11: Global Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Region, 2020A-2031F

Figure 12: Global Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Region, 2021E-2031F

Figure 13: North America Pharmaceutical Unit Dose Packaging Market Share Analysis By Product, 2021E & 2031F

Figure 14: North America Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Product, 2020A-2031F

Figure 15: North America Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Product, 2021E-2031F

Figure 16: North America Pharmaceutical Unit Dose Packaging Market Share Analysis By Material, 2021E & 2031F

Figure 17: North America Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Material, 2020A-2031F

Figure 18: North America Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Material, 2021E-2031F

Figure 19: North America Pharmaceutical Unit Dose Packaging Market Share Analysis By End Use, 2021E & 2031F

Figure 20: North America Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By End Use, 2020A-2031F

Figure 21: North America Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By End Use, 2021E-2031F

Figure 22: North America Pharmaceutical Unit Dose Packaging Market Share Analysis By Country, 2021E & 2031F

Figure 23: North America Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Country, 2020A-2031F

Figure 24: North America Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Country, 2021E-2031F

Figure 25: Latin America Pharmaceutical Unit Dose Packaging Market Share Analysis By Product, 2021E & 2031F

Figure 26: Latin America Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Product, 2020A-2031F

Figure 27: Latin America Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Product, 2021E-2031F

Figure 28: Latin America Pharmaceutical Unit Dose Packaging Market Share Analysis By Material, 2021E & 2031F

Figure 29: Latin America Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Material, 2020A-2031F

Figure 30: Latin America Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Material, 2021E-2031F

Figure 31: Latin America Pharmaceutical Unit Dose Packaging Market Share Analysis By End Use, 2021E & 2031F

Figure 32: Latin America Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By End Use, 2020A-2031F

Figure 33: Latin America Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By End Use, 2021E-2031F

Figure 34: Latin America Pharmaceutical Unit Dose Packaging Market Share Analysis By Country, 2021E & 2031F

Figure 35: Latin America Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Country, 2020A-2031F

Figure 36: Latin America Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Country, 2021E-2031F

Figure 37: Europe Pharmaceutical Unit Dose Packaging Market Share Analysis By Product, 2021E & 2031F

Figure 38: Europe Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Product, 2020A-2031F

Figure 39: Europe Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Product, 2021E-2031F

Figure 40: Europe Pharmaceutical Unit Dose Packaging Market Share Analysis By Material, 2021E & 2031F

Figure 41: Europe Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Material, 2020A-2031F

Figure 42: Europe Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Material, 2021E-2031F

Figure 43: Europe Pharmaceutical Unit Dose Packaging Market Share Analysis By End Use, 2021E & 2031F

Figure 44: Europe Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By End Use, 2020A-2031F

Figure 45: Europe Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By End Use, 2021E-2031F

Figure 46: Europe Pharmaceutical Unit Dose Packaging Market Share Analysis By Country, 2021E & 2031F

Figure 47: Europe Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Country, 2020A-2031F

Figure 48: Europe Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Country, 2021E-2031F

Figure 49: MEA Pharmaceutical Unit Dose Packaging Market Share Analysis By Product, 2021E & 2031F

Figure 50: MEA Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Product, 2020A-2031F

Figure 51: MEA Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Product, 2021E-2031F

Figure 52: MEA Pharmaceutical Unit Dose Packaging Market Share Analysis By Material, 2021E & 2031F

Figure 53: MEA Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Material, 2020A-2031F

Figure 54: MEA Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Material, 2021E-2031F

Figure 55: MEA Pharmaceutical Unit Dose Packaging Market Share Analysis By End Use, 2021E & 2031F

Figure 56: MEA Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By End Use, 2020A-2031F

Figure 57: MEA Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By End Use, 2021E-2031F

Figure 58: MEA Pharmaceutical Unit Dose Packaging Market Share Analysis By Country, 2021E & 2031F

Figure 59: MEA Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Country, 2020A-2031F

Figure 60: MEA Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Country, 2021E-2031F

Figure 61: East Asia Pharmaceutical Unit Dose Packaging Market Share Analysis By Product, 2021E & 2031F

Figure 62: East Asia Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Product, 2020A-2031F

Figure 63: East Asia Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Product, 2021E-2031F

Figure 64: East Asia Pharmaceutical Unit Dose Packaging Market Share Analysis By Material, 2021E & 2031F

Figure 65: East Asia Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Material, 2020A-2031F

Figure 66: East Asia Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Material, 2021E-2031F

Figure 67: East Asia Pharmaceutical Unit Dose Packaging Market Share Analysis By End Use, 2021E & 2031F

Figure 68: East Asia Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By End Use, 2020A-2031F

Figure 69: East Asia Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By End Use, 2021E-2031F

Figure 70: East Asia Pharmaceutical Unit Dose Packaging Market Share Analysis By Country, 2021E & 2031F

Figure 71: East Asia Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Country, 2020A-2031F

Figure 72: East Asia Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Country, 2021E-2031F

Figure 73: South Asia Pharmaceutical Unit Dose Packaging Market Share Analysis By Product, 2021E & 2031F

Figure 74: South Asia Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Product, 2020A-2031F

Figure 75: South Asia Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Product, 2021E-2031F

Figure 76: South Asia Pharmaceutical Unit Dose Packaging Market Share Analysis By Material, 2021E & 2031F

Figure 77: South Asia Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Material, 2020A-2031F

Figure 78: South Asia Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Material, 2021E-2031F

Figure 79: South Asia Pharmaceutical Unit Dose Packaging Market Share Analysis By End Use, 2021E & 2031F

Figure 80: South Asia Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By End Use, 2020A-2031F

Figure 81: South Asia Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By End Use, 2021E-2031F

Figure 82: South Asia Pharmaceutical Unit Dose Packaging Market Share Analysis By Country, 2021E & 2031F

Figure 83: South Asia Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Country, 2020A-2031F

Figure 84: South Asia Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Country, 2021E-2031F

Figure 85: Oceania Pharmaceutical Unit Dose Packaging Market Share Analysis By Product, 2021E & 2031F

Figure 86: Oceania Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Product, 2020A-2031F

Figure 87: Oceania Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Product, 2021E-2031F

Figure 88: Oceania Pharmaceutical Unit Dose Packaging Market Share Analysis By Material, 2021E & 2031F

Figure 89: Oceania Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Material, 2020A-2031F

Figure 90: Oceania Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Material, 2021E-2031F

Figure 91: Oceania Pharmaceutical Unit Dose Packaging Market Share Analysis By End Use, 2021E & 2031F

Figure 92: Oceania Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By End Use, 2020A-2031F

Figure 93: Oceania Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By End Use, 2021E-2031F

Figure 94: Oceania Pharmaceutical Unit Dose Packaging Market Share Analysis By Country, 2021E & 2031F

Figure 95: Oceania Pharmaceutical Unit Dose Packaging Market Y-o-Y Analysis By Country, 2020A-2031F

Figure 96: Oceania Pharmaceutical Unit Dose Packaging Market Attractiveness Analysis By Country, 2021E-2031F

Need specific information?

Request Customization

Explore Packaging Insights

View Reports
Google translate

Pharmaceutical Unit Dose Packaging Market